We are live on
!
Find out more
AB
Amalgamated Bank Portfolio holdings
AUM
$14.5B
1-Year Est. Return
44.3%
This Fund
S&P 500
This Quarter
Est. Return
+0.49%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$11.8B
AUM Growth
-$631M
(-5.1%)
Cap. Flow
-$566M
Cap. Flow
% of AUM
-4.78%
Top 10 Holdings %
Top 10 Hldgs %
19.95%
Holding
2,211
New
30
Increased
190
Reduced
1,934
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$20.2M |
| 2 |
Match Group
MTCH
|
+$6.61M |
| 3 |
Analog Devices
ADI
|
+$6.39M |
| 4 |
GXO Logistics
GXO
|
+$5.97M |
| 5 |
JHG
Janus Henderson
JHG
|
+$5.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.2M |
| 2 |
Microsoft
MSFT
|
+$23.2M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$11.6M |
| 4 |
Amazon
AMZN
|
+$11.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$9.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.59% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
2101
DELISTED
Invacare Corporation
IVC
| $79K | ﹤0.01% |
16,694
-217
| -1% | -$1.58K |
|
|
MRC
2102
DELISTED
MRC Global
MRC
| $78K | ﹤0.01% |
10,634
-674
| -6% | -$5.6K |
|
2103
Theravance Biopharma
TBPH
$874M
| $78K | ﹤0.01% |
+10,559
| New | +$118K |
|
2104
Karyopharm Therapeutics
KPTI
$161M
| $76K | ﹤0.01% |
871
-35
| -4% | -$3.63K |
|
|
CMRX
2105
DELISTED
Chimerix, Inc.
CMRX
| $76K | ﹤0.01% |
12,277
-515
| -4% | -$3.54K |
|
|
PAE
2106
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $75K | ﹤0.01% |
12,597
-515
| -4% | -$3.94K |
|
2107
Akebia Therapeutics
AKBA
$343M
| $72K | ﹤0.01% |
25,033
-732
| -3% | -$2.09K |
|
2108
Kopin
KOPN
$687M
| $72K | ﹤0.01% |
14,078
-578
| -4% | -$3.51K |
|
2109
Standard BioTools
LAB
$303M
| $70K | ﹤0.01% |
10,560
-315
| -3% | -$2.07K |
|
|
CPRX
2110
DELISTED
Catalyst Pharmaceutical
CPRX
| $69K | ﹤0.01% |
13,045
-593
| -4% | -$3.24K |
|
2111
Alaunos Therapeutics
TCRT
$4.71M
| $69K | ﹤0.01% |
254
-10
| -4% | -$3.06K |
|
2112
Expro Ltd
XPRO
$1.78B
| $69K | ﹤0.01% |
3,917
-169
| -4% | -$2.87K |
|
|
VIEW
2113
DELISTED
View, Inc. Class A Common Stock
VIEW
| $69K | ﹤0.01% |
213
+15
| +8% | +$5.27K |
|
2114
Accuray
ARAY
$26.8M
| $66K | ﹤0.01% |
16,782
-687
| -4% | -$2.73K |
|
2115
TETRA Technologies
TTI
$1.14B
| $65K | ﹤0.01% |
20,944
-875
| -4% | -$2.81K |
|
|
ASXC
2116
DELISTED
Asensus Surgical, Inc.
ASXC
| $65K | ﹤0.01% |
34,971
-1,429
| -4% | -$3.21K |
|
|
BDSI
2117
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $61K | ﹤0.01% |
16,896
-692
| -4% | -$2.61K |
|
|
AMPE
2118
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $59K | ﹤0.01% |
118
-2
| -2% | -$927 |
|
2119
CytomX Therapeutics
CTMX
$708M
| $58K | ﹤0.01% |
11,386
-396
| -3% | -$2.12K |
|
|
SIEN
2120
DELISTED
Sientra, Inc.
SIEN
| $58K | ﹤0.01% |
1,008
-42
| -4% | -$2.87K |
|
|
AUD
2121
DELISTED
Audacy, Inc.
AUD
| $58K | ﹤0.01% |
15,884
-720
| -4% | -$2.52K |
|
2122
Geron
GERN
$949M
| $56K | ﹤0.01% |
40,600
-1,841
| -4% | -$2.46K |
|
|
LITS
2123
Lite Strategy Inc
LITS
$33.2M
| $54K | ﹤0.01% |
983
-41
| -4% | -$2.26K |
|
|
TRUE
2124
DELISTED
TrueCar
TRUE
| $54K | ﹤0.01% |
13,061
-761
| -6% | -$3.53K |
|
2125
Atossa Therapeutics
ATOS
$23.5M
| $53K | ﹤0.01% |
1,074
-48
| -4% | -$2.79K |
|
Similar funds
JFG
IFP
BBVA
SSA
HIIFS
BGC
Amalgamated Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Amalgamated Bank held 2,211 positions worth $11.8B, down 5.1% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Amalgamated Bank withdrew a net $566M in Q3 2021, closing 47 positions and reducing 1,934 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $11.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Amalgamated Bank opened a new position in GXO Logistics worth $5.97M.
- Amalgamated Bank's largest Q3 2021 buy was GXO Logistics: 76,088 shares worth $5.97M.
- Amalgamated Bank added most to Moderna in Q3 2021, an estimated $20.2M increase.
- Amalgamated Bank's biggest Q3 2021 reduction was Apple, cutting an estimated $23.2M.
- Amalgamated Bank fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $11.6M.
- Amalgamated Bank's ten largest holdings make up 20% of its $11.8B portfolio in Q3 2021.
- Amalgamated Bank opened 30 new positions and closed 47 in Q3 2021.
- Amalgamated Bank's portfolio value fell 5.1% quarter-over-quarter to $11.8B.
Based on Amalgamated Bank's 13F filing for Q3 2021, filed 29 Oct 2021.